[go: up one dir, main page]

WO2004018633A3 - Abca13 nucleic acids and proteins, and uses thereof - Google Patents

Abca13 nucleic acids and proteins, and uses thereof Download PDF

Info

Publication number
WO2004018633A3
WO2004018633A3 PCT/US2003/026335 US0326335W WO2004018633A3 WO 2004018633 A3 WO2004018633 A3 WO 2004018633A3 US 0326335 W US0326335 W US 0326335W WO 2004018633 A3 WO2004018633 A3 WO 2004018633A3
Authority
WO
WIPO (PCT)
Prior art keywords
abca13
proteins
nucleic acids
isoforms
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/026335
Other languages
French (fr)
Other versions
WO2004018633A2 (en
Inventor
Micheal C Dean
Isabelle Arnould-Reguigne
Catherine Prades
Marie-Francoise Rosier-Montus
Patrice Denefle
Sergey Shulenin
Tarmo Annilo
Marcia L Triunfol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
US Department of Health and Human Services
Original Assignee
Aventis Pharma SA
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA, US Department of Health and Human Services filed Critical Aventis Pharma SA
Priority to AU2003262789A priority Critical patent/AU2003262789A1/en
Publication of WO2004018633A2 publication Critical patent/WO2004018633A2/en
Anticipated expiration legal-status Critical
Publication of WO2004018633A3 publication Critical patent/WO2004018633A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This disclosure provides seven isoforms of a novel transporter protein, referred to as ABCA13, nucleic acid molecules encoding the disclosed isoforms, variants and fragments thereof, and methods of making and using these molecules. Also provided are methods of ameliorating, treating, detecting, prognosing, and diagnosing diseases and conditions believed to be associated with altered expression of ABCA13, such as hypercholesterolemia, drug resistance, retinal degeneration, or neurological disease. Kits are also provided.
PCT/US2003/026335 2002-08-20 2003-08-19 Abca13 nucleic acids and proteins, and uses thereof Ceased WO2004018633A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003262789A AU2003262789A1 (en) 2002-08-20 2003-08-19 Abca13 nucleic acids and proteins, and uses thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40500602P 2002-08-20 2002-08-20
US60/405,006 2002-08-20
US45450203P 2003-03-12 2003-03-12
US60/454,502 2003-03-12

Publications (2)

Publication Number Publication Date
WO2004018633A2 WO2004018633A2 (en) 2004-03-04
WO2004018633A3 true WO2004018633A3 (en) 2005-04-21

Family

ID=31949879

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/026335 Ceased WO2004018633A2 (en) 2002-08-20 2003-08-19 Abca13 nucleic acids and proteins, and uses thereof

Country Status (2)

Country Link
AU (1) AU2003262789A1 (en)
WO (1) WO2004018633A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10522240B2 (en) 2006-05-03 2019-12-31 Population Bio, Inc. Evaluating genetic disorders
US7702468B2 (en) 2006-05-03 2010-04-20 Population Diagnostics, Inc. Evaluating genetic disorders
EP2601609B1 (en) 2010-08-02 2017-05-17 Population Bio, Inc. Compositions and methods for discovery of causative mutations in genetic disorders
EP2766483B1 (en) 2011-10-10 2022-03-23 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders
EP2773779B1 (en) 2011-11-04 2020-10-14 Population Bio, Inc. Methods and compositions for diagnosing, prognosing, and treating neurological conditions
WO2013120018A1 (en) 2012-02-09 2013-08-15 Population Diagnostics, Inc. Methods and compositions for screening and treating developmental disorders
DK2895621T3 (en) 2012-09-14 2020-11-30 Population Bio Inc METHODS AND COMPOSITION FOR DIAGNOSIS, FORECAST AND TREATMENT OF NEUROLOGICAL CONDITIONS
EP2900835B1 (en) 2012-09-27 2025-04-30 Population Bio, Inc. Method for screening and treating developmental disorders
HRP20192262T1 (en) 2013-08-05 2020-03-06 Immatics Biotechnologies Gmbh NEW IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS PULMONARY CANCER, INCLUDING MICROCELLULAR PULMONARY CANCER (NSCLC)
TWI819228B (en) * 2013-08-05 2023-10-21 德商伊瑪提克斯生物科技有限公司 Novel peptides, cells, and their use against several tumors, methods for production thereof and pharmaceutical composition comprising the same
US10724096B2 (en) 2014-09-05 2020-07-28 Population Bio, Inc. Methods and compositions for inhibiting and treating neurological conditions
CN107849565A (en) * 2015-06-30 2018-03-27 埃泽瑞斯公司 The coding polyribonucleotide and its preparation of ATP combination cassette families
US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
CA3108807A1 (en) 2018-08-08 2020-02-13 Pml Screening, Llc Methods for assessing the risk of developing progressive multifocal leukoencephalopathy caused by john cunningham virus by genetic testing
CN114875148A (en) * 2022-05-11 2022-08-09 中南大学湘雅医院 Familial multiple lipoma detection kit and application of primer group

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074836A1 (en) * 2000-03-31 2001-10-11 Hyseq, Inc. Novel bone marrow nucleic acids and polypeptides
US20020127647A1 (en) * 2000-11-28 2002-09-12 John Shutter ATP-binding cassette transporter-like molecules and uses thereof
US6555323B2 (en) * 2000-02-08 2003-04-29 Pfizer Inc. Assay for ABCA1

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555323B2 (en) * 2000-02-08 2003-04-29 Pfizer Inc. Assay for ABCA1
WO2001074836A1 (en) * 2000-03-31 2001-10-11 Hyseq, Inc. Novel bone marrow nucleic acids and polypeptides
US20020127647A1 (en) * 2000-11-28 2002-09-12 John Shutter ATP-binding cassette transporter-like molecules and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BROCCARDO ET AL: "The ABCA subclass of mammalian transporters", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1461, 1999, pages 395 - 404, XP004273105 *
PRADES ET AL: "The human ATP binding cassette gene ABCA13, located on chromosome 7p12.3, encodes a 5058 amino acid protein with an axtracellular domain encoded i part by a 4.8-kb conserved exon", CYTOGENET. GENOM. RES., vol. 98, 2002, pages 160 - 168, XP002985952 *

Also Published As

Publication number Publication date
WO2004018633A2 (en) 2004-03-04
AU2003262789A1 (en) 2004-03-11
AU2003262789A8 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
WO2004018633A3 (en) Abca13 nucleic acids and proteins, and uses thereof
WO2007021494A3 (en) Albumin fusion proteins
WO2004000997A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2008033413A3 (en) Albumin fusion proteins
WO2007146038A3 (en) Albumin fusion proteins
WO2002050277A3 (en) Protein and nucleic acids encoding same
WO2006096737A3 (en) Diagnostic and therapeutic target for macular degeneration
WO2004081043A3 (en) Baff mutants with at least one amino acid substitution and methods of their production
WO2003040325A3 (en) Novel proteins and nucleic acids encoding same
WO2001029217A3 (en) Novel polypeptides and polynucleotides encoding same
WO2002000691A3 (en) Polynucleotides and polypeptides encoded thereby
WO2003083046A3 (en) Novel proteins and nucleic acids encoding same
PL1709064T3 (en) Dna sequence, and recombinant production of the grass pollen allergen lol p 4
WO2000068364A3 (en) Mutations in nucleic acid molecules encoding 11-cis retinol dehydrogenase, the mutated proteins, and uses thereof
WO2003064628A3 (en) Novel proteins and nucleic acids encoding same
WO2003029424A3 (en) Novel proteins and nucleic acids encoding same
WO2005023979A3 (en) Isolated s. mansoni nucleic acid molecules and uses thereof
WO2001046231A3 (en) Polynucleotides and polypeptides encoded thereby
WO2003064591A3 (en) Abca8 nucleic acids and proteins, and uses thereof
WO2002026985A3 (en) G-protein coupled recptors
WO2005035564A3 (en) Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
WO2001074897A3 (en) Protein amf-1 to amf-10 and nucleic acids encoding the same
WO2003057854A3 (en) Novel proteins and nucleic acids encoding same
WO2004048512A3 (en) Novel proteins and nucleic acids encoding same
WO2003085096A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP